Hematopoietic and Lymphoid Cell Neoplasm Clinical Trials

37 recruitingLast updated: June 17, 2026

There are 37 actively recruiting hematopoietic and lymphoid cell neoplasm clinical trials across 2 countries. Studies span Not Applicable, Phase 1, Phase 2, Phase 3, Early Phase 1. Top locations include Houston, Texas, United States, Columbus, Ohio, United States, Baltimore, Maryland, United States. Updated daily from ClinicalTrials.gov.


Hematopoietic and Lymphoid Cell Neoplasm Trials at a Glance

37 actively recruiting trials for hematopoietic and lymphoid cell neoplasm are listed on ClinicalTrialsFinder across 6 cities in 2 countries. The largest study group is Not Applicable with 7 trials, with the heaviest enrollment activity in Houston, Columbus, and Baltimore. Lead sponsors running hematopoietic and lymphoid cell neoplasm studies include M.D. Anderson Cancer Center, Fred Hutchinson Cancer Center, and Alliance for Clinical Trials in Oncology.

Browse hematopoietic and lymphoid cell neoplasm trials by phase

Treatments under study

About Hematopoietic and Lymphoid Cell Neoplasm Clinical Trials

Looking for clinical trials for Hematopoietic and Lymphoid Cell Neoplasm? There are currently 37 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Hematopoietic and Lymphoid Cell Neoplasm trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Hematopoietic and Lymphoid Cell Neoplasm clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 37 trials

Recruiting
Phase 1Phase 2

211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome

Hematopoietic and Lymphoid Cell NeoplasmAcute Myeloid Leukemia in RemissionChronic Myelomonocytic Leukemia+9 more
Fred Hutchinson Cancer Center30 enrolled1 locationNCT03670966
Recruiting

Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy

Breast CarcinomaEsophageal CarcinomaHead and Neck Carcinoma+6 more
M.D. Anderson Cancer Center5,000 enrolled1 locationNCT00991094
Recruiting
Early Phase 1

Alteplase Through an Indwelling Pleural Catheter for the Management of Symptomatic Septated Malignant Pleural Effusion

Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm
M.D. Anderson Cancer Center30 enrolled1 locationNCT06184321
Recruiting
Phase 1

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Malignant Solid NeoplasmHematopoietic and Lymphoid Cell NeoplasmRheumatoid Arthritis+11 more
National Cancer Institute (NCI)300 enrolled52 locationsNCT03816345
Recruiting
Not Applicable

Increasing Knowledge and Interest in Cancer Clinical Trials

Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm
Hayley Thompson384 enrolled1 locationNCT06501040
Recruiting

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Head and Neck CarcinomaMalignant Solid NeoplasmSarcoma+59 more
Alliance for Clinical Trials in Oncology2,000 enrolled746 locationsNCT05334069
Recruiting

The Effect of COVID-19 Pandemic on Adolescent and Young Adult Cancer Patients and Survivors

Malignant Solid NeoplasmHematopoietic and Lymphoid Cell NeoplasmCOVID-19 Infection
M.D. Anderson Cancer Center600 enrolled1 locationNCT04551378
Recruiting
Not Applicable

Expressive Writing for the Management of Stress in Cancer Survivors

Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm
M.D. Anderson Cancer Center414 enrolled1 locationNCT04776941
Recruiting

Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers

Anal CarcinomaMalignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+9 more
AIDS Malignancy Consortium200 enrolled8 locationsNCT05663502
Recruiting

Formulating Expert Consensus Guidelines in Cancer Care Using the Delphi Method

Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm
M.D. Anderson Cancer Center10 enrolled1 locationNCT05054413
Recruiting

Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies

Hematopoietic and Lymphoid Cell NeoplasmLymphomaLeukemia+3 more
M.D. Anderson Cancer Center100 enrolled1 locationNCT05011045
Recruiting

The Longitudinal Impact of Respiratory Viruses on Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Cell Transplantation (The RV-BOS Study)

Hematopoietic and Lymphoid Cell NeoplasmBronchiolitis Obliterans Syndrome
Fred Hutchinson Cancer Center250 enrolled4 locationsNCT05250037
Recruiting
Phase 3

A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients

Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm
Children's Oncology Group105 enrolled29 locationsNCT05711667
Recruiting
Early Phase 1

Addition of Cord Blood Tissue-Derived Mesenchymal Stromal Cells to Ruxolitinib for the Treatment of Steroid-Refractory Acute Graft Versus Host Disease

Steroid refractory Graft Versus Host DiseaseHematopoietic and Lymphoid Cell Neoplasm
M.D. Anderson Cancer Center24 enrolled1 locationNCT04744116
Recruiting
Not Applicable

Exercise Program (TEAM Me) for the Improvement of Movement and Mobility in Pediatric and Adolescent and Young Adult Patients With Cancer Undergoing a Blood Stem Cell Transplant

Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm
M.D. Anderson Cancer Center60 enrolled2 locationsNCT04678427
Recruiting
Phase 3

Comparing Brief Behavioral Therapy (BBT-CI) and Healthy Eating Education Learning (HEAL) for Cancer-Related Sleep Problems While Receiving Cancer Treatment

Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm
University of Rochester NCORP Research Base400 enrolled153 locationsNCT04829539
Recruiting

Outcomes After Chimeric Antigen Receptor Therapy and Radiation Therapy for Hematologic Malignancies

Hematopoietic and Lymphoid Cell Neoplasm
M.D. Anderson Cancer Center100 enrolled1 locationNCT04888338
Recruiting
Phase 1

Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients

Malignant Solid NeoplasmHematopoietic and Lymphoid Cell NeoplasmSymptomatic COVID-19 Infection Laboratory-Confirmed+4 more
M.D. Anderson Cancer Center30 enrolled1 locationNCT05101213
Recruiting
Phase 1Phase 2

Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia

Malignant Solid NeoplasmHematopoietic and Lymphoid Cell NeoplasmCOVID-19 Infection+2 more
M.D. Anderson Cancer Center70 enrolled1 locationNCT04565665
Recruiting
Not Applicable

Vertebroplasty With Radiation Therapy for Spine Metastatic Cancer Patients With Indeterminate Lesion (SINS Criteria)

Malignant Solid NeoplasmHematopoietic and Lymphoid Cell NeoplasmMetastatic Malignant Neoplasm in the Spine
Ohio State University Comprehensive Cancer Center200 enrolled1 locationNCT05178472